10.1038/nrm3012 115 UeharaY.MinowaO.MoriC.ShiotaK.KunoJ.NodaT.et al (1995)
For those discounts received for drugs acquired through the 340B Program, since those discounts may be dependent on whether a 340B eligible patient receives the drug, we are asking for hospitals to separately list their acquisition costs for those drug NDCs acquired through the 340B program and those drug NDCs acquired outside of the 340B program
While preclinical and clinical trials are underway to reduce the generation and overall brain disease load, current treatment focuses on alleviating symptoms
Abbasinejad, MD , at Cape Fear Physical Medicine takes the time to assess each patients health history, lifestyle, and weight loss goals to determine the most effective treatment
This cell line can be used for screening GLP-1R agonists, hormones, and other activator molecules
Ko LW, Su CH, Yang MH, Liu SY, Su TP